<DOC>
	<DOCNO>NCT02656121</DOCNO>
	<brief_summary>Recently , special emphasis recently direct potential role vitamin D regulatory peptide ( e.g . adipokines follistatin ) associate metabolic role genetic factor development PCOS relate co-morbidities . The aim study compare effect vitamin D supplementation therapy Metformin therapy plasma concentration adipokines ( ghrelin , resistin adiponectin ) , follistatin activins participant diagnose PCOS .</brief_summary>
	<brief_title>Does Vitamin D Break Vicious Circle Polycystic Ovarian Syndrome Insuline Resistance ?</brief_title>
	<detailed_description>Research question : In PCOS patient , effect vitamin D supplementation therapy plasma concentration adipokines ( ghrelin , resistin adiponectin ) , follistatin activins ? Research hypothesis : There significant effect vitamin D supplementation therapy plasma concentration adipokines ( ghrelin , resistin adiponectin ) , follistatin activin .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Alfacalcidol</mesh_term>
	<criteria>diagnose PCOS case accord National Institute Health criterion ( NIH consensus criterion ) Rotterdam criterion 1 PCOS patient child bearing age ; le 18 year 45 year . 2 Patients congenital adrenal hyperplasia , androgensecreting tumor , Cushing 's syndrome , hyperprolactinemia virilize ovarian adrenal tumor . 3 PCOS patient medical illness . 4 PCOS patient already vitamin D supplement .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>PCOS , vitamin D</keyword>
</DOC>